Lucid Diagnostics Inc Strategic Asset Allocation Index
Lucid Diagnostics Inc strategic asset allocation index. Lucid Diagnostics Inc (LUCD) has a Strategic Asset Allocation Index of 9.2% as of June 2023. Strategic assets (PP&E of $1.39 Million plus long-term investments of $-) total $1.39 Million, measured against net assets of $15.07 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See LUCD equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Lucid Diagnostics Inc (2021–2022)
Strategic asset allocation index of Lucid Diagnostics Inc from 2021 to 2022. This chart shows how Lucid Diagnostics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of June 2023, the index stands at 9.2%, representing strategic assets of $1.39 Million against net assets of $15.07 Million USD. Check Lucid Diagnostics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Lucid Diagnostics Inc Strategic Asset Allocation Index by Year (2021–2022)
Lucid Diagnostics Inc strategic asset allocation index by year from 2021 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Lucid Diagnostics Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Lucid Diagnostics Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 6.9% | $1.59 Million | $1.59 Million | $- | $23.05 Million | ▲ +5.1 pp |
| 2021 | 1.8% | $971.00K | $971.00K | $- | $54.74 Million | — |